姑息治疗中的迷幻辅助疗法——来自一个国际研讨会的见解。

IF 2.7 4区 医学 Q2 HEALTH CARE SCIENCES & SERVICES
Anna Schuldt, Ian C Clark, Yasmin Schmid, Michael Ljuslin, Christopher Boehlke, Sivan Schipper, Megan B Sands, David Blum
{"title":"姑息治疗中的迷幻辅助疗法——来自一个国际研讨会的见解。","authors":"Anna Schuldt, Ian C Clark, Yasmin Schmid, Michael Ljuslin, Christopher Boehlke, Sivan Schipper, Megan B Sands, David Blum","doi":"10.3390/healthcare13182275","DOIUrl":null,"url":null,"abstract":"<p><p><b>Background:</b> Evidence is growing that psychedelic substances have positive effects in the setting of Palliative Care (PC), focusing on special needs in this patient population. After a scoping review of the literature, no published expert recommendations guiding best practice for psychedelic-assisted therapy (PAT) towards the end of life were identified. <b>Objective:</b> To draw conclusions from first-hand experienced professionals on PAT in PC (PATPC). <b>Setting, Design, Participants:</b> An international workshop with experts was held in Wasserfallen, Switzerland. A thematic analysis of a semi-structured, questionnaire-based qualitative study with 13 experts in PC, oncology, psychiatry/psychology, and PAT from Europe, the United States, and Oceania was made. <b>Measurements:</b> The questionnaire was designed to elicit the participant's perspectives on (A) special considerations on PATPC, (B) specific characteristics of PATPC (versus mental illness), and (C) the relevance of these differences during preparation, substance dosing session, and integration in PATPC. <b>Results:</b> (A) Special Considerations included (non-medicalized) setting, potential need, and possibility to reduce preparation time. (B) Distinguishing characteristics included the patient's intrinsic motivation for treatment success, the importance of anxiety, depression, and spiritual distress as indications for PATPC, and the importance of sufficient integration of the psychedelic experience into life in the face of limited time due to the life-limiting illness. (C) Flexibility in setting and timing of preparation, choosing the appropriate dosage of the psychedelic substance depending on the patient's intended focus, low/medium (relational issues), higher for transcendental experiences, considering mental capacity and vulnerability for the individual. In addition, respondents noted that for therapists, knowledge about transcendental states, such as mystical experiences, existential aspects of life-threatening illness, and the role of therapists' own self-experience/inner work, as well as good knowledge of the theoretical basis for treatment, was highlighted. <b>Conclusions:</b> This study highlights special considerations for PAT PC and could be a first step towards specific treatment recommendations (guidelines) for PATPC.</p>","PeriodicalId":12977,"journal":{"name":"Healthcare","volume":"13 18","pages":""},"PeriodicalIF":2.7000,"publicationDate":"2025-09-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12469609/pdf/","citationCount":"0","resultStr":"{\"title\":\"Psychedelic-Assisted Therapy in Palliative Care-Insights from an International Workshop.\",\"authors\":\"Anna Schuldt, Ian C Clark, Yasmin Schmid, Michael Ljuslin, Christopher Boehlke, Sivan Schipper, Megan B Sands, David Blum\",\"doi\":\"10.3390/healthcare13182275\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p><b>Background:</b> Evidence is growing that psychedelic substances have positive effects in the setting of Palliative Care (PC), focusing on special needs in this patient population. After a scoping review of the literature, no published expert recommendations guiding best practice for psychedelic-assisted therapy (PAT) towards the end of life were identified. <b>Objective:</b> To draw conclusions from first-hand experienced professionals on PAT in PC (PATPC). <b>Setting, Design, Participants:</b> An international workshop with experts was held in Wasserfallen, Switzerland. A thematic analysis of a semi-structured, questionnaire-based qualitative study with 13 experts in PC, oncology, psychiatry/psychology, and PAT from Europe, the United States, and Oceania was made. <b>Measurements:</b> The questionnaire was designed to elicit the participant's perspectives on (A) special considerations on PATPC, (B) specific characteristics of PATPC (versus mental illness), and (C) the relevance of these differences during preparation, substance dosing session, and integration in PATPC. <b>Results:</b> (A) Special Considerations included (non-medicalized) setting, potential need, and possibility to reduce preparation time. (B) Distinguishing characteristics included the patient's intrinsic motivation for treatment success, the importance of anxiety, depression, and spiritual distress as indications for PATPC, and the importance of sufficient integration of the psychedelic experience into life in the face of limited time due to the life-limiting illness. (C) Flexibility in setting and timing of preparation, choosing the appropriate dosage of the psychedelic substance depending on the patient's intended focus, low/medium (relational issues), higher for transcendental experiences, considering mental capacity and vulnerability for the individual. In addition, respondents noted that for therapists, knowledge about transcendental states, such as mystical experiences, existential aspects of life-threatening illness, and the role of therapists' own self-experience/inner work, as well as good knowledge of the theoretical basis for treatment, was highlighted. <b>Conclusions:</b> This study highlights special considerations for PAT PC and could be a first step towards specific treatment recommendations (guidelines) for PATPC.</p>\",\"PeriodicalId\":12977,\"journal\":{\"name\":\"Healthcare\",\"volume\":\"13 18\",\"pages\":\"\"},\"PeriodicalIF\":2.7000,\"publicationDate\":\"2025-09-12\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12469609/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Healthcare\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.3390/healthcare13182275\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"HEALTH CARE SCIENCES & SERVICES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Healthcare","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3390/healthcare13182275","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}
引用次数: 0

摘要

背景:越来越多的证据表明,致幻剂在姑息治疗(PC)的环境中具有积极作用,重点关注这一患者群体的特殊需求。在对文献进行范围审查后,没有发表的专家建议指导致幻剂辅助治疗(PAT)走向生命终结的最佳实践。目的:从专业人士的第一手经验中得出结论。环境、设计、参与者:在瑞士的瓦瑟费尔举行了一场由专家参加的国际研讨会。本文对来自欧洲、美国和大洋洲的13位PC、肿瘤学、精神病学/心理学和PAT专家进行的半结构化、基于问卷的定性研究进行了专题分析。测量方法:问卷的设计是为了引起参与者对以下方面的观点:(A) PATPC的特殊考虑,(B) PATPC的特定特征(与精神疾病相比),以及(C)这些差异在PATPC的准备、物质剂量和整合过程中的相关性。结果:(A)特殊考虑包括(非医疗化)环境、潜在需求和减少准备时间的可能性。(B)区别性特征包括患者对治疗成功的内在动机,焦虑、抑郁和精神痛苦作为PATPC适应症的重要性,以及面对由于限制生命的疾病而导致的有限时间,将迷幻体验充分融入生活的重要性。(C)在准备的环境和时间上的灵活性,根据病人的预期焦点选择合适的迷幻物质剂量,低/中(关系问题),超觉体验的剂量更高,考虑到个人的心理能力和脆弱性。此外,受访者指出,对于治疗师来说,关于超验状态的知识,如神秘体验、危及生命的疾病的存在方面、治疗师自己的自我体验/内在工作的作用,以及对治疗理论基础的良好了解,都是重点。结论:本研究强调了对PATPC的特殊考虑,可能是针对PATPC的具体治疗建议(指南)的第一步。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Psychedelic-Assisted Therapy in Palliative Care-Insights from an International Workshop.

Background: Evidence is growing that psychedelic substances have positive effects in the setting of Palliative Care (PC), focusing on special needs in this patient population. After a scoping review of the literature, no published expert recommendations guiding best practice for psychedelic-assisted therapy (PAT) towards the end of life were identified. Objective: To draw conclusions from first-hand experienced professionals on PAT in PC (PATPC). Setting, Design, Participants: An international workshop with experts was held in Wasserfallen, Switzerland. A thematic analysis of a semi-structured, questionnaire-based qualitative study with 13 experts in PC, oncology, psychiatry/psychology, and PAT from Europe, the United States, and Oceania was made. Measurements: The questionnaire was designed to elicit the participant's perspectives on (A) special considerations on PATPC, (B) specific characteristics of PATPC (versus mental illness), and (C) the relevance of these differences during preparation, substance dosing session, and integration in PATPC. Results: (A) Special Considerations included (non-medicalized) setting, potential need, and possibility to reduce preparation time. (B) Distinguishing characteristics included the patient's intrinsic motivation for treatment success, the importance of anxiety, depression, and spiritual distress as indications for PATPC, and the importance of sufficient integration of the psychedelic experience into life in the face of limited time due to the life-limiting illness. (C) Flexibility in setting and timing of preparation, choosing the appropriate dosage of the psychedelic substance depending on the patient's intended focus, low/medium (relational issues), higher for transcendental experiences, considering mental capacity and vulnerability for the individual. In addition, respondents noted that for therapists, knowledge about transcendental states, such as mystical experiences, existential aspects of life-threatening illness, and the role of therapists' own self-experience/inner work, as well as good knowledge of the theoretical basis for treatment, was highlighted. Conclusions: This study highlights special considerations for PAT PC and could be a first step towards specific treatment recommendations (guidelines) for PATPC.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Healthcare
Healthcare Medicine-Health Policy
CiteScore
3.50
自引率
7.10%
发文量
0
审稿时长
47 days
期刊介绍: Healthcare (ISSN 2227-9032) is an international, peer-reviewed, open access journal (free for readers), which publishes original theoretical and empirical work in the interdisciplinary area of all aspects of medicine and health care research. Healthcare publishes Original Research Articles, Reviews, Case Reports, Research Notes and Short Communications. We encourage researchers to publish their experimental and theoretical results in as much detail as possible. For theoretical papers, full details of proofs must be provided so that the results can be checked; for experimental papers, full experimental details must be provided so that the results can be reproduced. Additionally, electronic files or software regarding the full details of the calculations, experimental procedure, etc., can be deposited along with the publication as “Supplementary Material”.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信